Lucid Diagnostics Inc.

LUCD Nasdaq CIK: 0001799011

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 360 MADISON AVENUE, NEW YORK, NY, 10017
Mailing Address 360 MADISON AVENUE, NEW YORK, NY, 10017
Phone 212 949 4319
Fiscal Year End 1231
EIN 825488042

Financial Overview

FY2025

$10.94M
Stockholders' Equity

Recent SEC Filings

Form Type Date Filed Document
S-3/A Shelf registration amendment March 26, 2026 View on SEC
424B5 Prospectus supplement March 26, 2026 View on SEC
8-K Current report of material events March 26, 2026 View on SEC
10-K Annual financial report March 25, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC

Annual Reports

10-K March 25, 2026
  • Revenue grew significantly from $0.7 million in 2022 to $2.8 million in 2023.
  • Strengthened balance sheet by converting $15.5 million of debt into common stock.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.